• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mts1(S100A4)及其肽与 Tag7(PGLYRP1)肽复合物具有细胞毒性活性。

Mts1 (S100A4) and Its Peptide Demonstrate Cytotoxic Activity in Complex with Tag7 (PGLYRP1) Peptide.

机构信息

Institute of Gene Biology (RAS), Moscow 119334, Russia.

Institute of Biomedical Chemistry, Pogodinskaya Street 10, Moscow 119121, Russia.

出版信息

Int J Mol Sci. 2024 Jun 16;25(12):6633. doi: 10.3390/ijms25126633.

DOI:10.3390/ijms25126633
PMID:38928339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11203719/
Abstract

Receptors of cytokines are major regulators of the immune response. In this work, we have discovered two new ligands that can activate the TNFR1 (tumor necrosis factor receptor 1) receptor. Earlier, we found that the peptide of the Tag (PGLYRP1) protein designated 17.1 can interact with the TNFR1 receptor. Here, we have found that the Mts1 (S100A4) protein interacts with this peptide with a high affinity (K = 1.28 × 10 M), and that this complex is cytotoxic to cancer cells that have the TNFR1 receptor on their surface. This complex induces both apoptosis and necroptosis in cancer cells with the involvement of mitochondria and lysosomes in cell death signal transduction. Moreover, we have succeeded in locating the Mts1 fragment that is responsible for protein-peptide interaction, which highly specifically interacts with the Tag7 protein (K = 2.96 nM). The isolated Mts1 peptide M7 also forms a complex with 17.1, and this peptide-peptide complex also induces the TNFR1 receptor-dependent cell death. Molecular docking and molecular dynamics experiments show the amino acids involved in peptide binding and that may be used for peptidomimetics' development. Thus, two new cytotoxic complexes were created that were able to induce the death of tumor cells via the TNFR1 receptor. These results may be used in therapy for both cancer and autoimmune diseases.

摘要

细胞因子受体是免疫反应的主要调节剂。在这项工作中,我们发现了两种可以激活 TNFR1(肿瘤坏死因子受体 1)受体的新配体。早些时候,我们发现了标记蛋白(PGLYRP1)的肽 17.1 可以与 TNFR1 受体相互作用。在这里,我们发现 Mts1(S100A4)蛋白与该肽具有高亲和力(K = 1.28 × 10 M)相互作用,并且该复合物对表面具有 TNFR1 受体的癌细胞具有细胞毒性。该复合物通过线粒体和溶酶体参与细胞死亡信号转导,诱导癌细胞凋亡和坏死。此外,我们成功定位了负责蛋白-肽相互作用的 Mts1 片段,该片段与 Tag7 蛋白高度特异性相互作用(K = 2.96 nM)。分离的 Mts1 肽 M7 也与 17.1 形成复合物,该肽-肽复合物也诱导 TNFR1 受体依赖性细胞死亡。分子对接和分子动力学实验表明了参与肽结合的氨基酸,这些氨基酸可能用于开发肽模拟物。因此,创建了两种新的细胞毒性复合物,它们能够通过 TNFR1 受体诱导肿瘤细胞死亡。这些结果可用于癌症和自身免疫性疾病的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/8d170fb2ef48/ijms-25-06633-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/1e597b220250/ijms-25-06633-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/0976ada91bbe/ijms-25-06633-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/8e8bddade372/ijms-25-06633-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/4eef2b448f7a/ijms-25-06633-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/8a0a8365d7dd/ijms-25-06633-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/82abc0d58669/ijms-25-06633-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/528301b69c37/ijms-25-06633-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/57d187e0c1f7/ijms-25-06633-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/87e237310058/ijms-25-06633-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/8d170fb2ef48/ijms-25-06633-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/1e597b220250/ijms-25-06633-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/0976ada91bbe/ijms-25-06633-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/8e8bddade372/ijms-25-06633-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/4eef2b448f7a/ijms-25-06633-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/8a0a8365d7dd/ijms-25-06633-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/82abc0d58669/ijms-25-06633-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/528301b69c37/ijms-25-06633-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/57d187e0c1f7/ijms-25-06633-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/87e237310058/ijms-25-06633-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c0/11203719/8d170fb2ef48/ijms-25-06633-g010.jpg

相似文献

1
Mts1 (S100A4) and Its Peptide Demonstrate Cytotoxic Activity in Complex with Tag7 (PGLYRP1) Peptide.Mts1(S100A4)及其肽与 Tag7(PGLYRP1)肽复合物具有细胞毒性活性。
Int J Mol Sci. 2024 Jun 16;25(12):6633. doi: 10.3390/ijms25126633.
2
A 12-mer Peptide of Tag7 (PGLYRP1) Forms a Cytotoxic Complex with Hsp70 and Inhibits TNF-Alpha Induced Cell Death.一种 12 肽的 Tag7(PGLYRP1)与 Hsp70 形成细胞毒性复合物并抑制 TNF-α诱导的细胞死亡。
Cells. 2020 Feb 20;9(2):488. doi: 10.3390/cells9020488.
3
Tag7 (PGLYRP1) in Complex with Hsp70 Induces Alternative Cytotoxic Processes in Tumor Cells via TNFR1 Receptor.与热休克蛋白70(Hsp70)结合的Tag7(肽聚糖识别蛋白1,PGLYRP1)通过肿瘤坏死因子受体1(TNFR1)在肿瘤细胞中诱导替代性细胞毒性过程。
J Biol Chem. 2015 Aug 28;290(35):21724-31. doi: 10.1074/jbc.M115.639732. Epub 2015 Jul 16.
4
The 12-Membered TNFR1 Peptide, as Well as the 16-Membered and 6-Membered TNF Peptides, Regulate TNFR1-Dependent Cytotoxic Activity of TNF.十二元环 TNFR1 肽、十六元环及六元环 TNF 肽调节 TNF 依赖的 TNFR1 细胞毒性活性。
Int J Mol Sci. 2024 Mar 31;25(7):3900. doi: 10.3390/ijms25073900.
5
Short Peptides of Innate Immunity Protein Tag7 (PGLYRP1) Selectively Induce Inhibition or Activation of Tumor Cell Death via TNF Receptor.天然免疫蛋白 Tag7(PGLYRP1)的短肽通过 TNF 受体选择性诱导肿瘤细胞死亡的抑制或激活。
Int J Mol Sci. 2023 Jul 12;24(14):11363. doi: 10.3390/ijms241411363.
6
Mechanisms of Action of the PGLYRP1/Tag7 Protein in Innate and Acquired Immunity.PGLYRP1/Tag7蛋白在固有免疫和获得性免疫中的作用机制
Acta Naturae. 2021 Jan-Mar;13(1):91-101. doi: 10.32607/actanaturae.11102.
7
The Tag7-Hsp70 cytotoxic complex induces tumor cell necroptosis via permeabilisation of lysosomes and mitochondria.Tag7-Hsp70细胞毒性复合物通过溶酶体和线粒体的通透性诱导肿瘤细胞坏死性凋亡。
Biochimie. 2016 Apr;123:32-6. doi: 10.1016/j.biochi.2016.01.007. Epub 2016 Jan 28.
8
A 8-mer Peptide of PGLYRP1/Tag7 Innate Immunity Protein Binds to TNFR1 Receptor and Inhibits TNFα-Induced Cytotoxic Effect and Inflammation.PGRP1/TAG7 先天免疫蛋白的 8 肽与 TNFR1 受体结合,抑制 TNFα 诱导的细胞毒性作用和炎症。
Front Immunol. 2021 Jun 7;12:622471. doi: 10.3389/fimmu.2021.622471. eCollection 2021.
9
HspBP1 in Complex with the Peptide of the Innate Immunity Protein Tag7 is Able to Lyse Tumor Cells Carrying TNFR1 Receptor.热休克蛋白结合蛋白 1 与天然免疫蛋白 Tag7 的肽段形成复合物,能够裂解携带 TNFR1 受体的肿瘤细胞。
Dokl Biochem Biophys. 2024 Apr;515(1):36-40. doi: 10.1134/S1607672923700631. Epub 2024 Jan 8.
10
Protein PGLYRP1/Tag7 Peptides Decrease the Proinflammatory Response in Human Blood Cells and Mouse Model of Diffuse Alveolar Damage of Lung through Blockage of the TREM-1 and TNFR1 Receptors.蛋白 PGLYRP1/Tag7 肽通过阻断 TREM-1 和 TNFR1 受体减少人血细胞和弥漫性肺泡损伤小鼠模型的促炎反应。
Int J Mol Sci. 2021 Oct 18;22(20):11213. doi: 10.3390/ijms222011213.

本文引用的文献

1
Programmed cell death in tumor immunity: mechanistic insights and clinical implications.肿瘤免疫中的程序性细胞死亡:机制见解与临床意义。
Front Immunol. 2024 Jan 12;14:1309635. doi: 10.3389/fimmu.2023.1309635. eCollection 2023.
2
MLKL polymerization-induced lysosomal membrane permeabilization promotes necroptosis.MLKL 聚合诱导溶酶体膜通透性增加促进坏死性凋亡。
Cell Death Differ. 2024 Jan;31(1):40-52. doi: 10.1038/s41418-023-01237-7. Epub 2023 Nov 23.
3
New perspectives in cancer immunotherapy: targeting IL-6 cytokine family.
癌症免疫治疗的新视角:靶向白细胞介素-6 细胞因子家族。
J Immunother Cancer. 2023 Nov;11(11). doi: 10.1136/jitc-2023-007530.
4
Bcl-B: an "unknown" protein of the Bcl-2 family.Bcl-B:Bcl-2 家族中的一种“未知”蛋白。
Biol Direct. 2023 Oct 30;18(1):69. doi: 10.1186/s13062-023-00431-4.
5
Short Peptides of Innate Immunity Protein Tag7 (PGLYRP1) Selectively Induce Inhibition or Activation of Tumor Cell Death via TNF Receptor.天然免疫蛋白 Tag7(PGLYRP1)的短肽通过 TNF 受体选择性诱导肿瘤细胞死亡的抑制或激活。
Int J Mol Sci. 2023 Jul 12;24(14):11363. doi: 10.3390/ijms241411363.
6
The application of Interleukin-2 family cytokines in tumor immunotherapy research.白细胞介素-2 家族细胞因子在肿瘤免疫治疗研究中的应用。
Front Immunol. 2023 Mar 2;14:1090311. doi: 10.3389/fimmu.2023.1090311. eCollection 2023.
7
The Role of Cytokines in the Metastasis of Solid Tumors to the Spine: Systematic Review.细胞因子在实体瘤脊柱转移中的作用:系统评价。
Int J Mol Sci. 2023 Feb 14;24(4):3785. doi: 10.3390/ijms24043785.
8
Programmed cell death: Past, present and future.程序性细胞死亡:过去、现在与未来
Biochem Biophys Res Commun. 2022 Dec 10;633:55-58. doi: 10.1016/j.bbrc.2022.09.022.
9
Tag7-Mts1 Complex Activates Chemotaxis of Regulatory T Cells.Tag7-Mts1 复合物激活调节性 T 细胞的趋化作用。
Dokl Biochem Biophys. 2022 Oct;506(1):181-184. doi: 10.1134/S1607672922050064. Epub 2022 Oct 27.
10
Spatial localization of cathepsins: Implications in immune activation and resolution during infections.组织蛋白酶的空间定位:在感染期间免疫激活和免疫应答中的意义。
Front Immunol. 2022 Aug 3;13:955407. doi: 10.3389/fimmu.2022.955407. eCollection 2022.